Literature DB >> 30127681

Intrafraction esophageal motion in patients with clinical T1N0 esophageal cancer.

Shuhei Sekii1, Yoshinori Ito1, Ken Harada1, Mayuka Kitaguchi1, Kana Takahashi1, Koji Inaba1, Naoya Murakami1, Hiroshi Igaki1, Ryohei Sasaki2, Jun Itami1.   

Abstract

AIM: To investigate the intrafraction movement of the esophagus using fiducial markers.
BACKGROUND: Studies on intrafraction esophageal motion using the fiducial markers are scarce.
MATERIALS AND METHODS: We retrospectively analyzed patients with clinical T1N0 esophageal cancer who had received fiducial markers at our hospital between July 2007 and December 2013. Real-Time Position Management System to track the patient's respiration was used, and each patient underwent three-dimensional computed tomography of the resting expiratory and inspiratory level. We used the center of the marker to calculate the distance between the expiratory and inspiratory breath-holds, which were measured with the radiotherapy treatment planning system in three directions: left-right (LR), superior-inferior (SI), and anterior-posterior (AP). The movements at each site were compared with the Kruskal-Wallis analysis and Wilcoxon rank sum test with a Bonferroni correction.
RESULTS: A total of 101 patients with 201 fiducial markers were included. The upper, middle and lower thoracic positions had 40, 77, and 84 markers, respectively. The mean absolute magnitudes of the shifts (standard deviation) were 0.18 (0.19) cm, 0.68 (0.46) cm, and 0.24 (0.24) cm in the LR, SI, and AP directions, respectively. From the cumulative frequency distribution, we assumed that 0.35 cm LR, 0.8 cm SI, and 0.3 cm AP in the upper; 0.5 cm LR, 1.55 cm SI, and 0.55 cm AP in the middle; and 0.75 cm LR, 1.9 cm SI, and 0.95 cm AP in the lower thoracic esophagus covered 95% of the cases.
CONCLUSIONS: The internal margin based on the site of esophagus was estimated.

Entities:  

Keywords:  Esophageal cancer; Fiducial marker; Gastrointestinal cancer; Intrafraction motion

Year:  2018        PMID: 30127681      PMCID: PMC6097394          DOI: 10.1016/j.rpor.2018.07.013

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  15 in total

1.  Real-time monitoring of a digestive tract marker to reduce adverse effects of moving organs at risk (OAR) in radiotherapy for thoracic and abdominal tumors.

Authors:  Takayuki Hashimoto; Hiroki Shirato; Mototsugu Kato; Koichi Yamazaki; Nobuaki Kurauchi; Toshiaki Morikawa; Shinichi Shimizu; Yong Chan Ahn; Yasuyuki Akine; Kazuo Miyasaka
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-04-01       Impact factor: 7.038

Review 2.  Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus.

Authors:  R Wong; R Malthaner
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

3.  Four-dimensional measurement of the displacement of internal fiducial markers during 320-multislice computed tomography scanning of thoracic esophageal cancer.

Authors:  Hideomi Yamashita; Satoshi Kida; Akira Sakumi; Akihiro Haga; Saori Ito; Tsuyoshi Onoe; Kae Okuma; Kenji Ino; Masaaki Akahane; Kuni Ohtomo; Keiichi Nakagawa
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-08-01       Impact factor: 7.038

4.  Is dose escalation achievable for esophageal carcinoma?

Authors:  Laure Vieillevigne; Marie Vidal; Françoise Izar; Michel Rives
Journal:  Rep Pract Oncol Radiother       Date:  2015-01-05

5.  Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group.

Authors:  J S Cooper; M D Guo; A Herskovic; J S Macdonald; J A Martenson; M Al-Sarraf; R Byhardt; A H Russell; J J Beitler; S Spencer; S O Asbell; M V Graham; L L Leichman
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

6.  A global assessment of the oesophageal adenocarcinoma epidemic.

Authors:  Gustaf Edgren; Hans-Olov Adami; Elisabete Weiderpass; Elisabete Weiderpass Vainio; Olof Nyrén
Journal:  Gut       Date:  2012-08-23       Impact factor: 23.059

7.  Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy.

Authors:  Yvette Seppenwoolde; Hiroki Shirato; Kei Kitamura; Shinichi Shimizu; Marcel van Herk; Joos V Lebesque; Kazuo Miyasaka
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-07-15       Impact factor: 7.038

8.  Determination of respiratory motion for distal esophagus cancer using four-dimensional computed tomography.

Authors:  Brian P Yaremko; Thomas M Guerrero; Mary F McAleer; M Kara Bucci; Josue Noyola-Martinez; Linda T Nguyen; Peter A Balter; Rudy Guerra; Ritsuko Komaki; Zhongxing Liao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-12       Impact factor: 7.038

9.  Implications of respiratory motion as measured by four-dimensional computed tomography for radiation treatment planning of esophageal cancer.

Authors:  Abhijit A Patel; John A Wolfgang; Andrzej Niemierko; Theodore S Hong; Torunn Yock; Noah C Choi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-05-01       Impact factor: 7.038

10.  Motion of the esophagus due to cardiac motion.

Authors:  Jacob Palmer; Jinzhong Yang; Tinsu Pan; Laurence E Court
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

View more
  1 in total

Review 1.  Cardiotoxicity of radiation therapy in esophageal cancer.

Authors:  Milan Vošmik; Miroslav Hodek; David Buka; Petra Sýkorová; Jakub Grepl; Petr Paluska; Simona Paulíková; Igor Sirák
Journal:  Rep Pract Oncol Radiother       Date:  2020-02-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.